Hisamitsu Pharmaceutical Co., Inc. (TYO:4530)
Japan flag Japan · Delayed Price · Currency is JPY
6,040.00
0.00 (0.00%)
Inactive · Last trade price on May 8, 2026

TYO:4530 Financials Overview

Millions JPY. Fiscal year is Mar - Feb.

Revenue & Profits

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingFeb '26 Feb '26 Feb '25 Feb '24 Feb '23 Feb '22
Revenue
163,024163,024156,006141,706128,330120,193
Revenue Growth
4.50%4.50%10.09%10.42%6.77%4.96%
Gross Profit
96,12196,12191,19678,97172,70070,067
Operating Income
17,91817,91818,89613,16811,6019,337
Net Income
19,16019,16021,75813,96911,7429,658
Earnings Per Share
67.0667.0673.7945.3536.9729.71
EPS Growth
-9.12%-9.12%62.69%22.68%24.44%5.07%

Revenue by Segment

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingFeb '26 Feb '26 Feb '25 Feb '24 Feb '23 Feb '22
Pharmaceuticals Business
153,600163,024-138,455125,202117,291
Others
3,143-3,3523,2513,1272,901
Medicine and Related Product Business
--152,654---
Total
156,743163,024156,006141,706128,329120,192

Cash & Debt

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingFeb '26 Feb '26 Feb '25 Feb '24 Feb '23 Feb '22
Cash & Investments
118,638118,638129,116125,321136,868142,431
Total Debt
2,3752,3753,8562,1002,2952,460
Net Cash (Debt)
116,263116,263125,260123,221134,573139,971
Net Cash Growth
-7.18%-7.18%1.65%-8.44%-3.86%4.15%
Net Cash Per Share
406.88406.88424.79400.05423.69430.57

Cash Flow & CapEx

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingFeb '26 Feb '26 Feb '25 Feb '24 Feb '23 Feb '22
Operating Cash Flow
17,47817,47818,76518,18812,72719,199
Capital Expenditures
-7,995-7,995-13,627-12,924-7,859-3,610
Free Cash Flow
9,4839,4835,1385,2644,86815,589
Free Cash Flow Growth
84.57%84.57%-2.39%8.13%-68.77%700.26%

Margins

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingFeb '26 Feb '26 Feb '25 Feb '24 Feb '23 Feb '22
Gross Margin
58.96%58.96%58.46%55.73%56.65%58.29%
Operating Margin
10.99%10.99%12.11%9.29%9.04%7.77%
Pretax Margin
14.51%14.51%18.39%13.54%12.56%10.78%
Profit Margin
11.75%11.75%13.95%9.86%9.15%8.04%
FCF Margin
5.82%5.82%3.29%3.72%3.79%12.97%

Dividends

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingNov '26 Feb '26 Feb '25 Feb '24 Feb '23 Feb '22
Dividend Per Share
45.00011.25021.50021.25021.00021.000
Dividend Per Share Growth
20.00%-47.67%1.18%1.19%0%0.60%
Dividend Yield
0.74%0.19%0.52%0.57%0.58%0.62%

Valuation

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingNov '26 Feb '26 Feb '25 Feb '24 Feb '23 Feb '22
PE Ratio
22.5266.2149.49110.50113.47135.66
P/FCF Ratio
44.84133.77209.59293.23273.7084.04
PS Ratio
2.617.786.9010.8910.3810.90